Sthanu Subramanian/X
Apr 5, 2026, 16:16
Sthanu Subramanian։ Understanding Antiphospholipid Syndrome and Its Thrombotic Risks
Sthanu Subramanian, Pediatrician, shared a post on X:
”Antiphospholipid Syndrome (APS), also known as Hughes’ Syndrome, an autoimmune condition where the body produces abnormal antibodies (such as Lupus antibody, Anti-cardiolipin, and Anti-β2-glycoprotein 1) that attack cell membrane components.
This process increases the risk of dangerous blood clots in both arteries and veins.”
Stay updated with Hemostasis Today.
-
Jul 5, 2026, 22:51Shahzaib Akram: What Are We Actually Seeing When a Sickling Test Goes Positive?
-
Jul 5, 2026, 21:474 Tips for Exercising with A Bleeding Disorder – Haemophilia Foundation Australia
-
Jul 5, 2026, 21:06Heghine Khachatryan: Toward Personalized Management of Glanzmann Thrombasthenia
-
Jul 5, 2026, 21:06Priyanka Kumari: IV Fluids and Isotonic Solution
-
Jul 5, 2026, 21:05Ahmed Rizq: Would You Thrombolyse a Stable Patient?
-
Jul 5, 2026, 21:03Emmanuel Obeng Ofori: Diagnosing Anaemia – Why Treating the Root Cause Matters More Than Simply Raising the Haemoglobin
-
Jul 5, 2026, 21:02Mohit Koladia: The Pharmacist’s Role in Stroke Prevention for Atrial Fibrillation
-
Jul 5, 2026, 20:22J. Meireles-Brandao: Exploring the Approach to Thrombophillias
-
Jul 5, 2026, 20:13Kavya Keerthana: The Platelet Count Everyone Calls ‘Reactive’ Until It Isn’t